Trusted by over 100K subscribers
100% online process
No memberships requirements
FDA-Regulated Pharmacies
Transparent pricing, no hidden fees
Board certified physicians
US sourced ingredients

The maximum recommended dose of tirzepatide for weight loss is 15 mg per week, as used in the FDA-approved medication Zepbound®. Most people start at a much lower dose, increasing gradually to help the body adjust and minimize side effects.
Tirzepatide is the active ingredient in Zepbound® (FDA-approved for chronic weight management) and Mounjaro®(FDA-approved for type 2 diabetes but sometimes prescribed off-label for weight loss).
It’s approved for adults with:
Compounded tirzepatide contains the same active ingredient but is not FDA-approved. It may be considered when customized dosing or ingredient adjustments are needed.
Tirzepatide is taken once a week by subcutaneous injection.
With compounded tirzepatide, dosing can start as low as 2.0 mg weekly and may be increased in smaller increments depending on patient tolerance and goals.
Tirzepatide is injected under the skin (abdomen, thigh, or upper arm).
Rotating injection sites can help reduce irritation.
Most side effects are gastrointestinal, especially during dose increases:
These symptoms usually improve after the body adjusts. In some cases, anti-nausea medication (like ondansetron) can help during the transition period.
Tirzepatide should be combined with healthy eating, regular exercise, proper hydration, and good sleep. While medication can help control appetite and reduce cravings, long-term weight management is most successful when paired with sustainable lifestyle habits.